Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)

Xiamen Amoytop Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	2,376	2,093	1,517	1,123	789.39	725.27
Other Revenue	10.48	7.74	10	9.51	4.54	4.4
Revenue	2,387	2,100	1,527	1,132	793.93	729.67
Revenue Growth (YoY)	39.11%	37.55%	34.86%	42.61%	8.81%	62.77%
Cost of Revenue	159.54	143.16	171.01	126.99	85.65	81.74
Gross Profit	2,227	1,957	1,356	1,005	708.29	647.93
Selling, General & Admin	1,180	1,057	841.02	700.65	503.55	482.54
Research & Development	264.74	228.52	148.58	79.74	74.23	50.49
Other Operating Expenses	12.09	10.95	7.64	5.55	3.83	3.67
Operating Expenses	1,456	1,297	995.83	783.6	581.42	538.98
Operating Income	770.76	659.88	360.06	221.64	126.86	108.95
Interest Expense	-0.49	-0.51	-0.62	-1.07	-2.46	-3.38
Interest & Investment Income	8.62	10.17	8.09	7.84	3.67	0.45
Currency Exchange Gain (Loss)	-0.1	-1.03	0.48	-0.47	-0.95	-0.01
Other Non Operating Income (Expenses)	21.84	-0.39	-0.25	-0.24	0.39	-5.42
EBT Excluding Unusual Items	800.64	668.13	367.77	227.69	127.51	100.6
Gain (Loss) on Sale of Investments	3.41	2.65	0.4	1.8	3.96	-
Gain (Loss) on Sale of Assets	-0.81	-0.87	0.03	-1.8	-1.13	-0.01
Asset Writedown	-12.76	-12.76	-	-	-	-
Other Unusual Items	-30.88	-16.49	-12.27	-12.4	8.73	-9.58
Pretax Income	759.6	640.65	355.93	215.29	139.07	91.01
Income Tax Expense	101.98	85.21	68.91	34.09	22.5	26.72
Net Income	657.61	555.45	287.02	181.2	116.57	64.29
Net Income to Common	657.61	555.45	287.02	181.2	116.57	64.29
Net Income Growth	84.96%	93.52%	58.40%	55.44%	81.31%	301.76%
Shares Outstanding (Basic)	406	405	404	403	402	357
Shares Outstanding (Diluted)	406	405	404	403	402	357
Shares Change (YoY)	0.55%	0.29%	0.39%	0.18%	12.54%	-10.72%
EPS (Basic)	1.62	1.37	0.71	0.45	0.29	0.18
EPS (Diluted)	1.62	1.37	0.71	0.45	0.29	0.18
EPS Growth	83.94%	92.96%	57.78%	55.17%	61.11%	350.00%
Free Cash Flow	267.07	223.64	143.99	43.85	-26.2	78.48
Free Cash Flow Per Share	0.66	0.55	0.36	0.11	-0.07	0.22
Dividend Per Share	0.410	0.410	0.213	0.100	0.050	0.025
Dividend Growth	92.49%	92.49%	113.00%	100.00%	100.00%	-
Gross Margin	93.31%	93.18%	88.80%	88.78%	89.21%	88.80%
Operating Margin	32.30%	31.42%	23.58%	19.58%	15.98%	14.93%
Profit Margin	27.55%	26.45%	18.80%	16.00%	14.68%	8.81%
Free Cash Flow Margin	11.19%	10.65%	9.43%	3.87%	-3.30%	10.75%
EBITDA	831.52	712.11	403.23	260.33	165.03	146.73
EBITDA Margin	34.84%	33.90%	26.41%	22.99%	20.79%	20.11%
D&A For EBITDA	60.76	52.23	43.17	38.69	38.17	37.78
EBIT	770.76	659.88	360.06	221.64	126.86	108.95
EBIT Margin	32.30%	31.42%	23.58%	19.58%	15.98%	14.93%
Effective Tax Rate	13.43%	13.30%	19.36%	15.83%	16.18%	29.36%
Revenue as Reported	2,387	2,100	1,527	1,132	793.93	729.67
Advertising Expenses	-	4.94	2.94	5.48	6.38	4.79

Source: S&P Capital IQ. Standard template. Financial Sources.